PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ammi visnaga seeds have been used to treat renal colic and kidney stones; in rat models, it highly reduced the incidence of calcium oxalate deposition in kidneys [PMID:31940874, PMID:12452606]. A case report indicated a patient recovered completely from ureteral stones after 10 days of seed use [PMID:26692756].
Aqueous extract of Ammi visnaga was investigated for antihypertensive activity in rats [PMID:38115615].
A case report noted that HDL-cholesterol levels returned to normal after 10 days of using A. visnaga seeds [PMID:26692756].
Fruit hydroalcoholic extract showed neuroprotective, anticonvulsant, and anti-inflammatory properties in a PTZ-induced seizure mouse model [PMID:41182468].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 24925412 (2014) — Chromones. · Chemical immunology and allergy
- 2.PMID: 32491405 (2026) — Mast cell stabilisers. · European journal of pharmacology
- 3.PMID: 31940874 (2020) — Ammi Visnaga L., a Potential Medicinal Plant: A Review. · Molecules (Basel, Switzerland)
- 4.PMID: 38797603 (2024) — Therapeutic potential and pharmacological mechanism of visnagin. · Journal of integrative medicine
- 5.PMID: 37009254 (2023) — Ammi-visnaga extract; a novel phyto-antiviral agent against bovine rotavirus. · Virusdisease